ES
Elphogene, s.r.o.
–/10Traction
Elphogene develops liquid biopsy testing tools that utilize circulating tumor DNA analysis to detect cancer at early stages. This technology provides oncologists with non-invasive diagnostic options, improving patient outcomes by enabling timely treatment decisions.
- Biotechnology
- Healthcare Technology
Updated 4 months ago
Funding
Raised to date
$250KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Elphogene develops liquid biopsy testing tools that utilize circulating tumor DNA analysis to detect cancer at early stages. This technology provides oncologists with non-invasive diagnostic options, improving patient outcomes by enabling timely treatment decisions.